Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 10, 2015 - Issue 3
Submit an article Journal homepage
1,136
Views
4
CrossRef citations to date
0
Altmetric
Review

Potential for dipeptidyl peptidase-4 inhibitor and sodium glucose cotransporter 2 inhibitor single-pill combinations

Devada Singh-FrancoCollege of Pharmacy, Nova Southeastern University, 3200 S University Drive Fort Lauderdale, FL, USACorrespondence[email protected]
Pages 305-317 | Published online: 21 Jan 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Hirotaka Watada, Toshimasa Yamauchi, Fumiko Yamamoto, Atsushi Taniguchi, Larisa Yarush, Clemens Heilmann & Atsutaka Yasui. (2020) Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials. Expert Opinion on Drug Safety 19:9, pages 1193-1202.
Read now
Huan Yu & Vincent C Woo. (2017) Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin. Diabetes, Metabolic Syndrome and Obesity 10, pages 317-332.
Read now

Articles from other publishers (2)

Hytham M. Ahmed, Mahmoud A. Omar, Hany A. Batakoushy & Mohamed A. Abdel Hamid. (2020) HPTLC-densitometric analysis of selected antidiabetic drugs in presence of their degradation products. Microchemical Journal 154, pages 104560.
Crossref
Jianwen Li & He Lian. (2016) Recent development of single preparations and fixed-dose combination tablets for the treatment of non-insulin-dependent diabetes mellitus. Archives of Pharmacal Research 39:6, pages 731-746.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.